Global 3D Bioprinted Human Tissue Market Projected to Grow at 13.3% CAGR, Reaching $3.18 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the 3D Bioprinted Human Tissue Industry Market Size Be by 2025?
The market for 3D bioprinted human tissue has seen substantial growth in the past few years. The market is projected to expand from $1.70 billion in 2024 to $1.93 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.7%. Reasons behind the significant growth during the historical period include rising demand for organ transplants, increasing prevalence of chronic illnesses, amplified investment in regenerative medicine, progression in stem cell research, and the growing trend of personalized medicine.

What's the Long-Term Growth Forecast for the 3D Bioprinted Human Tissue Market Size Through 2029?
The market for 3D bioprinted human tissue is anticipated to witness significant expansion in the following years, with projections indicating a growth to $3.18 billion by 2029 at a compound annual growth rate (CAGR) of 13.3%. Factors contributing to the anticipated growth during the forecast period include the escalating demand for organ transplants, a surge in chronic diseases, increased funding in regenerative medicine, advancements in stem cell research, and a rise in personalized medicine usage. Key trends anticipated during the forecast period encompass advancements in bio-ink technology, novel developments in tissue engineering, swift progress in stem cell bioprinting, R&D initiatives, and the advent of multi-material and multi-cell printing systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/3d-bioprinted-human-tissue-global-market-report

What Are the Key Growth Drivers Fueling the 3D Bioprinted Human Tissue Market Expansion?
The growth of the 3D bioprinted human tissue market is predicted to be propelled by the rising need for organ transplants. This medical procedure involves transferring organs from a donor to a recipient with the objective of replacing damaged or malfunctioning organs. The escalation in the demand for these operations stems from patients wanting procedures that not only save lives but also reduce wait times, increase survival rates, and provide accessible and dependable transplant options. 3D bioprinted human tissue provides a revolutionary solution to organ transplants by facilitating the production of patient-customized, functional tissues. These reduce the risk of rejection and decrease the reliance on donated organs. To illustrate, the Organ Procurement and Transplantation Network, a department of the health and human services in the US, reported in January 2024 that the number of organ transplants from both living and deceased donors totaled 46,632 in 2023. This represented an 8.7% and 12.7% rise over 2022 and 2021 respectively-2021 being the first year in which over 40,000 organ transplants took place. Hence, the surging demand for organ transplants is fuelling the growth of the 3D bioprinted human tissue market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27196&type=smp

What Are the Key Trends Driving 3D Bioprinted Human Tissue Market Growth?
Key players in the 3D bioprinted human tissue sector are driving innovation in the field, with a particular focus on optimization of patient-derived samples. This technique helps enhance the use of scarce patient cells to develop multiple superior 3D tissue models pertinent to a range of uses, from drug testing to disease research and regenerative medicine. An illustrative example of such advancements is the RASTRUM solution, pioneered by Australia's Inventia Life Science Pty Ltd., launched in January 2025. Part of Inventia Life Science suite, RASTRUM was laid out to substantially improve the efficiency, precision, and reproducibility of creating intricate 3D models of human tissues that closely replicate actual human tissues. Its application spans across areas such as drug discovery, disease modeling, and regenerative medicine. By leveraging cutting-edge drop-on-demand bioprinting technology, it automates and scales up the production of 3D cell cultures in typical laboratory plate formats, leading to substantial reductions in manual effort and inconsistency. As a result, researchers can carry out high-volume, consistent experimentation with tissue models that have biological relevance, consequently hastening discoveries and enhancing predictability in preclinical research outcomes.

How Is the 3D Bioprinted Human Tissue Market Segmented?
The 3D bioprinted human tissue market covered in this report is segmented

1) By Tissue Type: Skin, Cartilage, Liver, Bone, Heart, Other Tissue Types
2) By Technology: Extrusion-Based, Inkjet Bioprinting, Laser-Assisted Bioprinting, Microfluidic And Acoustic, Magnetic Levitation, Hybrid Or 4D
3) By Materials: Natural Biomaterials, Synthetic Biomaterials, Decellularized Extracellular Matrices, Hydrogels, Composite Materials, Other Materials
4) By Application: Tissue Engineering, Cosmetic Surgery, Drug Testing And Development, Food Testing
5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Academic Research Institutions, Contract Research Organizations, Hospitals And Clinics

Subsegments:
1) By Skin: Wound Healing Applications, Cosmetic Testing Models, Skin Graft Replacements
2) By Cartilage: Joint Repair Models, Nasal Reconstruction, Ear Reconstruction
3) By Liver: Toxicity Testing Models, Disease Modeling, Transplant Research
4) By Bone: Orthopedic Implants, Cranial Repair Models, Bone Graft Substitutes
5) By Heart: Cardiac Patch Development, Heart Valve Models, Myocardial Regeneration
6) By Other Tissue Types: Kidney Models, Lung Tissue Constructs, Pancreatic Tissue Models

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27196&type=smp

Which Companies Are Leading the Charge in 3D Bioprinted Human Tissue Market Innovation?
Major companies operating in the 3D bioprinted human tissue market are 3D Systems Corporation, Inventia Life Science PTY LTD., Aspect Biosystems Ltd., Cellink Global AB, Prellis Biologics Inc., Cyfuse Biomedical K.K., Poietis SAS, Fluidform LLC, Tissuelabs, Brinter Oy, EpiBone Inc., Carcinotech Ltd., VoxCell BioInnovation Inc., Organovo Holdings Inc., Biolife 4D, Vivax-bio, CollPlant Biotechnologies Ltd., Xolo, Copner Biotech, and TissueTinker.

Which Regions Are Leading the Global 3D Bioprinted Human Tissue Market in Revenue?
North America was the largest region in the 3D bioprinted human tissue market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3d bioprinted human tissue market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27196

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert: Saumya Sahay: Americas +1 310-496-7795: Asia +44 7882 955267 & +91 8897263534: Europe +44 7882 955267: Email: saumyas@tbrc.info: The Business Research Company - www.thebusinessresearchcompany.com: Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.